Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/2010
07/08/2010US20100172896 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
07/08/2010US20100172895 Human CGRP Receptor Binding Proteins
07/08/2010US20100172894 Methods for purification of single domain antigen binding molecules
07/08/2010US20100172862 Stable antibody compositions and methods of stabilizing same
07/08/2010US20100172844 Albumin binding molecules and uses thereof
07/08/2010US20100172837 MN Gene and Protein
07/08/2010US20100172832 Diagnosis and treatment of malignant neoplasms
07/08/2010CA2748757A1 Anti-lymphotoxin antibodies
07/08/2010CA2748586A1 Isolated peptides of rabbit factor vii
07/08/2010CA2747123A1 High affinity human antibodies to pcsk9
07/08/2010CA2740806A1 Anti-pd-l1 antibodies and their use to enhance t-cell function
07/08/2010CA2737453A1 Combination gas vaccines and therapeutics
07/07/2010EP2204454A1 Predicting treatment response in cancer subjects
07/07/2010EP2204448A1 Method of detecting liver cancer, diagnostic for liver cancer and remedy for cancer
07/07/2010EP2204447A2 Method for generating diversity
07/07/2010EP2204385A1 Pseudomonas exotoxin A mutants and uses thereof
07/07/2010EP2204381A1 Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies
07/07/2010EP2204191A1 Monoclonal antibodies to hepatocyte growth factor
07/07/2010EP2204190A1 IgM production by transformed cells and methods for quantifying said IgM production
07/07/2010EP2204188A1 Subunit vaccine against respiratory syncytial virus infection
07/07/2010EP2203480A1 Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (vegf)
07/07/2010EP2203479A2 Inhibition of angiogenesis
07/07/2010EP2203477A2 Influenza virus haemagglutinin-specific monoclonal antibodies
07/07/2010EP2203474A1 Method for purifying fc-fusion proteins
07/07/2010EP2203469A2 Methods and compositions for detection of ehrlichia chaffeensis (p120)
07/07/2010EP2203180A1 Single ifn-beta fused to a mutated igg fc fragment
07/07/2010EP1920239B1 Detection and measurement of blood-feeding activity
07/07/2010EP1900811B1 Enriched central nervous system cell populations
07/07/2010EP1682178B1 Methods of therapy for cancers expressing the cd40 antigen
07/07/2010EP1597367B1 Glycoprotein antigen sima135 expressed in metastatic human tumor cells
07/07/2010EP1507866B1 Carotene synthase gene and uses therefor
07/07/2010EP1446158B1 Efficient inhibition of hiv-1 viral entry through a novel fusion protein including cd4
07/07/2010EP1383919B1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
07/07/2010EP1274834B1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
07/07/2010EP1079862B1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody
07/07/2010CN1778816B Human cell surface membrane molecule and use thereof
07/07/2010CN101768591A Translation adjusting element and application thereof
07/07/2010CN101768218A Preparation method for PCV-II Cap protein monoclonal antibody, antibody and application
07/07/2010CN101768217A Copper ion antigen and preparation method and application thereof
07/07/2010CN101768214A Human tumor marker-Tim17 polypeptide and application thereof
07/07/2010CN101037671B Hybridoma cell line and anti-human erythrocyte surface H antigen monoclonal antibodies generated thereof
07/06/2010US7750204 Methods for producing antibody
07/06/2010US7750136 Using ribosome-inactivating protein (RIP)/cytotoxin fusion to target and destroy tumor cells
07/06/2010US7750133 Vascular endothelial cell growth inhibitor, VEGI-192a
07/06/2010US7750129 Process for the purification of antibodies
07/06/2010US7750128 Modified Fc molecules
07/06/2010US7750127 Modified Fc molecules
07/06/2010US7750126 Antibodies that bind to a member of the IL-6/G-CSF/MGF family
07/06/2010US7750125 C35 tumor antigen specific monoclonal for use in diagnosis, prevention and treatment of cell proliferative disorders
07/06/2010US7750124 Delta-like 4 receptor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders
07/06/2010US7750123 Immunoglobulin for treatment and prevention of severe acute respiratory syndrome and/or coronavirus related disorders
07/06/2010US7750122 Anti-TrkB monoclonal antibodies and uses thereof
07/06/2010US7750121 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents
07/06/2010US7750117 Mixing protein with a saccharide compound in a liquid suspension and then drying to produce a solid that contains the protein and the saccharide
07/06/2010US7749962 administering to mammal with breast cancer as adjuvant therapy an agent effective in blocking interaction of integrin with extracellular matrix protein of bone marrow microenvironment or that downregulates expression of integrin; integrin is alpha 5 beta 1 and extracellular matrix protein is fibronectin
07/06/2010US7749758 Human and mammalian stem cell-derived neuron survival factors
07/06/2010US7749753 modulation of transport proteins in biological cells; genetic engineering; antibodies
07/06/2010US7749746 Nucleic acid encoding 238P1B2 useful in detecting cancer
07/06/2010US7749721 Immuno enzymatic quantification method for cholesterol ester transferring protein (CETP)
07/06/2010US7749719 bioassay to detect diagnosis of skin cancer; isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; immunogen or vaccine for cancer prevention and treatment; immunotherapy
07/06/2010US7749718 Method for raising or isolating an antibody to DCRS5
07/06/2010US7749714 Compositions and methods for diagnosing and treating prostate cancer
07/06/2010US7749713 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
07/06/2010US7749712 Using immunoglobulins as screening tools in detection of tetrahydrocannabinol, morphine and amphetamine in fluid samples; drug screening
07/06/2010US7749697 Method for linking sequences of interest
07/06/2010US7749518 Viral protein for use in devloping vaccine for treatment and preventon of infection, vision, arthritic and respiratory system disorders
07/06/2010US7749517 administering to a human or non-human animal infected by or exposed to anthrax a polypeptide that inhibits binding between protective antigen (PA) and human capillary morphogenesis protein-2 (CMG-2) at a level effective to reduce the severity of anthrax infection
07/06/2010US7749506 Envelope protein for use as immunization tool in treatment and prevention of viral disease in crustaceans
07/06/2010US7749505 Immunogenic polypeptides for use in targeted treatment and prevention of cell proliferative disorders associated with respiratory system
07/06/2010US7749504 Anti-TAT188 antibodies
07/06/2010US7749502 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with Porphyromonas gingivalis
07/06/2010US7749500 Antibodies to IL-17 polypeptides and therapeutic uses thereof
07/06/2010US7749499 Immunoglobulin for use in diagnosis, prevention and treatment of neisserial infection; immunootherapeutics
07/06/2010US7749498 Binding native human tissue factor (TF) and does not substantially bind non-native tissue factor; superior anticoagulant activity by binding with high affinity and specificity; reducing cancer cell tissue factor activity and detecting cancer cells that express TF; factor X binding is inhibited
07/06/2010CA2522067C Detection, characterization and treatment of viral infection and methods thereof
07/06/2010CA2370814C Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
07/06/2010CA2363537C Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods
07/06/2010CA2318354C Biomarkers and targets for diagnosis, prognosis and management of prostate disease
07/06/2010CA2264509C Novel monoclonal antibody recognizing cell surface antigen cd14
07/06/2010CA2209360C Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen
07/06/2010CA2162729C Cloning and recombinant production of crf (corticotropin releasing factor) receptor(s)
07/06/2010CA2150785C Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
07/01/2010WO2010075548A2 Immunoglobulin variants with altered binding to protein a
07/01/2010WO2010075475A1 SOLUBLE FMS-LIKE TYROSINE KINASE-1 (sFLT-1) ANTIBODY AND RELATED COMPOSITION, KIT, METHODS OF USING, AND MATERIALS AND METHOD FOR MAKING
07/01/2010WO2010075417A1 Survivin specific t cell receptor for treating cancer
07/01/2010WO2010075375A1 Compositions, methods and related uses for cleaving modified dna
07/01/2010WO2010075238A1 Human cgrp receptor binding proteins
07/01/2010WO2010074656A1 Monoclonal antibodies specific to the fusion peptide from hemagglutinin from influenza a viruses and uses thereof
07/01/2010WO2010074266A1 Anti-cd4 antibody
07/01/2010WO2010074249A1 Nucleic acid derived from hepatitis c virus, and expression vector, transformed cell and hepatitis c virus particles each prepared by using same
07/01/2010WO2010074218A1 Anti-human midkine antibody
07/01/2010WO2010074192A1 Diagnosis and treatment of cancer using anti-lgr7 antibody
07/01/2010WO2010074049A1 Anti-hs6st2 antibody and use thereof
07/01/2010WO2010073694A1 Diagnosis of treatment of cancer using anti-tm4sf20 antibody
07/01/2010WO2010073647A1 Human anti-human influenza virus antibody
07/01/2010WO2010073257A1 An immunodominant b-cell epitope based protein vaccine against anthrax and method of preparation thereof
07/01/2010WO2010073247A2 Egfr-homing double-stranded rna vector for systemic cancer treatment
07/01/2010WO2010073204A1 Anti-hcv monoclonal antibody as a medicament for the therapeutic treatment and prevention of hcv infections
07/01/2010WO2010073119A1 Stable pharmaceutical composition containing at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents
07/01/2010WO2010073012A2 Antibodies